Pfizer and BioNTech receive Emergency Use Authorization for COVID-19 vaccine in adolescents
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated
COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study
A new Prenetics Innovation Technology Centre will be established for advanced molecular diagnostics
Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
The test offers 98.0% clinical sensitivity for samples with PCR Ct values up to 31
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
AI could hold the key to more targeted treatment, according to new research
Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies
Explore topics from in vitro diagnostics, flow cytometry, pharmaceutical solid-phase microextraction, liquid handling and much more
An MIT team has created polymers that replicate the structure of mucins, the molecules that give mucus its unique antimicrobial properties
The program was developed in partnership with Color Health, Inc., a California-based leader in distributed healthcare services